Skip to main content
Advertisement
Advertisement
PRGO
PRGO logo
PERRIGO COMPANY PLC
16.04
USD
Sponsored
-0.90
-5.31%
Nov 19, 15:59 UTC -5
Closed
exchange

After-Market

16.14

+0.11
+0.65%

PERRIGO COMPANY PLC (PRGO) Earnings

PRGO Earnings Reports

Positive Surprise Ratio

PRGO beat 27 of 43 last estimates.

63%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

PERRIGO COMPANY PLC earnings per share and revenue

On Nov 04, 2026, PRGO reported earnings of 0.60 USD per share (EPS) for Q3 26, beating the estimate of 0.50 USD, resulting in a 18.44% surprise. Revenue reached 988.60 million, compared to an expected 1.01 billion, with a -1.82% difference. The market reacted with a +0.83% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%
logo
Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%
logo
MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%
logo
Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%
logo
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-
Actual
$0.10
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
logo
Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%
logo
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
For Q3 2026, PERRIGO COMPANY PLC reported EPS of $0.60, beating estimates by 18.44%, and revenue of $988.60M, -1.82% below expectations.
The stock price moved up 0.83%, changed from $15.70 before the earnings release to $15.83 the day after.
The next earning report is scheduled for --.
Based on -- analysts, PERRIGO COMPANY PLC is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement